Ampio Pharmaceuticals, Inc. (APH0.F)

0.1810 0.0000 (0.00%) As of 08:11AM CEST. Market open.

Ampio Pharmaceuticals, Inc.

373 Inverness Parkway
Suite 200
Englewood, CO 80112
United States
720 437 6500
https://ampiopharma.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 8

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Michael A. Martino	CEO & Director	548.14k	N/A	1957
Dr. David Bar-Or M.D.	Founder & Chairman of Scientific Advisory Board	145.6k	N/A	1949
Mr. Daniel G. Stokely CPA, CPA	CFO, Corp. Sec. & Treasurer	346.73k	N/A	1964
Dr. Howard Levy M.B.B.Ch., M.M.M., Ph.D.	Chief Medical Officer	N/A	N/A	1954
April Ramirez	Clinical Trial Mang.	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It focuses on the preclinical development of AR-300, a novel proprietary, small molecule formulation for the treatment of osteoarthritis of the knee. The company is headquartered in Englewood, Colorado.

Corporate Governance

Ampio Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.